These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23959472)

  • 1. Prognostic role of cytovillin expression in patients with osteosarcoma: a meta-analysis.
    Guo S; Bai R; Zhao W; Wang Y; Zhao Z; Feng W
    Tumour Biol; 2014 Jan; 35(1):469-73. PubMed ID: 23959472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Letter regarding "Prognostic role of cytovillin expression in patients with osteosarcoma: a meta-analysis" by Guo et al.
    Wang P; Sun L; Yu L; Wang H
    Tumour Biol; 2014 Jul; 35(7):6175. PubMed ID: 24504679
    [No Abstract]   [Full Text] [Related]  

  • 3. The prognostic value of elevated ezrin in patients with osteosarcoma.
    Lun DX; Hu YC; Xu ZW; Xu LN; Wang BW
    Tumour Biol; 2014 Feb; 35(2):1263-6. PubMed ID: 24014052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis.
    Wen X; Liu H; Yu K; Liu Y
    Tumour Biol; 2014 Jan; 35(1):845-8. PubMed ID: 24037915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of vascular endothelial growth factor expression as a biomarker of prognosis in patients with osteosarcoma.
    Chen D; Zhang YJ; Zhu KW; Wang WC
    Tumour Biol; 2013 Jun; 34(3):1895-9. PubMed ID: 23589053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of VEGF expression in osteosarcoma: a meta-analysis.
    Yu XW; Wu TY; Yi X; Ren WP; Zhou ZB; Sun YQ; Zhang CQ
    Tumour Biol; 2014 Jan; 35(1):155-60. PubMed ID: 23907576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of p53 as a biomarker of survival in patients with osteosarcoma.
    Fu HL; Shao L; Wang Q; Jia T; Li M; Yang DP
    Tumour Biol; 2013 Dec; 34(6):3817-21. PubMed ID: 24014053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma.
    Li H; Zhang K; Liu LH; Ouyang Y; Bu J; Guo HB; Xiao T
    Tumour Biol; 2014 Jun; 35(6):5487-91. PubMed ID: 24577891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does serum alkaline phosphatase level really indicate the prognosis in patients with osteosarcoma? A meta-analysis.
    Gu R; Sun Y
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S468-S472. PubMed ID: 29970708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of serum lactate dehydrogenase level in osteosarcoma: a meta-analysis.
    Chen J; Sun MX; Hua YQ; Cai ZD
    J Cancer Res Clin Oncol; 2014 Jul; 140(7):1205-10. PubMed ID: 24682390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of CD44V6 expression in osteosarcoma: a meta-analysis.
    Zhang Y; Ding C; Wang J; Sun G; Cao Y; Xu L; Zhou L; Chen X
    J Orthop Surg Res; 2015 Dec; 10():187. PubMed ID: 26697855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA MALAT1 as a valuable biomarker for prognosis in osteosarcoma: A systematic review and meta-analysis.
    Liu M; Yang P; Mao G; Deng J; Peng G; Ning X; Yang H; Sun H
    Int J Surg; 2019 Dec; 72():206-213. PubMed ID: 31734255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P16INK4a overexpression and survival in osteosarcoma patients: a meta analysis.
    Bu J; Li H; Liu LH; Ouyang YR; Guo HB; Li XY; Xiao T
    Int J Clin Exp Pathol; 2014; 7(9):6091-6. PubMed ID: 25337256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase 9 expression and survival of patients with osteosarcoma: a meta-analysis.
    Liu Y; Wang Y; Teng Z; Chen J; Li Y; Chen Z; Li Z; Zhang Z
    Eur J Cancer Care (Engl); 2017 Jan; 26(1):. PubMed ID: 26239566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of microRNAs in osteosarcoma: A meta-analysis.
    Kim YH; Goh TS; Lee CS; Oh SO; Kim JI; Jeung SH; Pak K
    Oncotarget; 2017 Jan; 8(5):8726-8737. PubMed ID: 28060730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Questions about XY Wen et al. entitled "Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis".
    Liu F; Zhang Q
    Tumour Biol; 2015 Feb; 36(2):557-8. PubMed ID: 25663465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic implications of RB1 tumour suppressor gene alterations in the clinical outcome of human osteosarcoma: a meta-analysis.
    Ren W; Gu G
    Eur J Cancer Care (Engl); 2017 Jan; 26(1):. PubMed ID: 26503016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of elevated vascular endothelial growth factor in patients with osteosarcoma: a meta-analysis and systemic review.
    Qu JT; Wang M; He HL; Tang Y; Ye XJ
    J Cancer Res Clin Oncol; 2012 May; 138(5):819-25. PubMed ID: 22274866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of vascular endothelial growth factor expression on overall survival in patients with osteosarcoma: a meta-analysis.
    Zhuang Y; Wei M
    Tumour Biol; 2014 Mar; 35(3):1745-9. PubMed ID: 24515658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of associations of the ezrin gene with human osteosarcoma response to chemotherapy and prognosis.
    Wang Z; He ML; Zhao JM; Qing HH; Wu Y
    Asian Pac J Cancer Prev; 2013; 14(5):2753-8. PubMed ID: 23803027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.